Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.48 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.48 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.48 |
| ▸ | PTPRC | P08575 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | ALOX5AP | P20292 | 6/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6737872 | 1.00 | RAB9A (0.54) | RAB9ACYP4F2CYP4A11MRGPRX4PTPRC | |
| SCHEMBL6735389 | 0.86 | RAB9A (0.57) | RAB9ACYP4F2CYP4A11KCNH2FFAR1 | |
| SCHEMBL6736357 | 0.82 | KCNQ3 (0.67) | RAB9AFFAR1LMNA | |
| SCHEMBL6736355 | 0.82 | KCNQ3 (0.67) | RAB9AFFAR1LMNA | |
| SCHEMBL6737896 | 0.80 | TAAR1 (0.42) | RAB9AALOX5APKDM4ESMN1; SMN2 | |
| SCHEMBL6737892 | 0.80 | TAAR1 (0.42) | RAB9AALOX5APKDM4ESMN1; SMN2 | |
| SCHEMBL10288351 | 0.78 | CYP4F2 (0.56) | CYP4F2CYP4A11KCNH2FFAR1NR4A2 | |
| SCHEMBL2136322 | 0.78 | CYP4F2 (0.56) | CYP4F2CYP4A11KCNH2FFAR1NR4A2 | |
| SCHEMBL318152 | 0.78 | SLC9A1 (0.52) | RAB9AFFAR1KDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL22492058 | 0.76 | KCNQ3 (0.56) | RAB9AFFAR1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040235830-A1 | Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases | BAYER AKTIENGESELLSCHAFT (DE) | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235830-A1 | Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases | CYP46A1, REN, CYP11B2 | RAB9A 4669/4885CYP4F2 70/4885CYP4A11 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.